The price-to-earnings ratio for Encompass Health Corp (NYSE: EHC) is 22.61x, which is above its average ratio. Moreover, the 36-month beta value for EHC is 0.94. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for EHC is 98.61M and currently, short sellers hold a 2.50% of that float. On April 19, 2024, EHC’s average trading volume was 660.15K shares.
EHC) stock’s latest price update
Encompass Health Corp (NYSE: EHC) has experienced a decline in its stock price by -1.34 compared to its previous closing price of 79.69. However, the company has seen a fall of -3.72% in its stock price over the last five trading days. Zacks Investment Research reported 2024-04-16 that Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
EHC’s Market Performance
Encompass Health Corp (EHC) has experienced a -3.72% fall in stock performance for the past week, with a 1.76% rise in the past month, and a 10.95% rise in the past quarter. The volatility ratio for the week is 1.98%, and the volatility levels for the past 30 days are at 1.88% for EHC.. The simple moving average for the past 20 days is -1.96% for EHC’s stock, with a 12.79% simple moving average for the past 200 days.
Analysts’ Opinion of EHC
Many brokerage firms have already submitted their reports for EHC stocks, with Barclays repeating the rating for EHC by listing it as a “Overweight.” The predicted price for EHC in the upcoming period, according to Barclays is $95 based on the research report published on March 06, 2024 of the current year 2024.
Barclays, on the other hand, stated in their research note that they expect to see EHC reach a price target of $57. The rating they have provided for EHC stocks is “Equal Weight” according to the report published on March 14th, 2023.
UBS gave a rating of “Buy” to EHC, setting the target price at $98 in the report published on September 24th of the previous year.
EHC Trading at 2.20% from the 50-Day Moving Average
After a stumble in the market that brought EHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -6.10% of loss for the given period.
Volatility was left at 1.88%, however, over the last 30 days, the volatility rate increased by 1.98%, as shares surge +2.54% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +8.91% upper at present.
During the last 5 trading sessions, EHC fell by -3.72%, which changed the moving average for the period of 200-days by +17.08% in comparison to the 20-day moving average, which settled at $80.29. In addition, Encompass Health Corp saw 17.84% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EHC starting from COLTHARP DOUGLAS E, who sale 11,215 shares at the price of $63.39 back on Nov 13 ’23. After this action, COLTHARP DOUGLAS E now owns 116,293 shares of Encompass Health Corp, valued at $710,919 using the latest closing price.
Charbonneau Elissa Joy, the Chief Medical Officer of Encompass Health Corp, sale 8,294 shares at $69.58 during a trade that took place back on Aug 17 ’23, which means that Charbonneau Elissa Joy is holding 23,081 shares at $577,097 based on the most recent closing price.
Stock Fundamentals for EHC
Current profitability levels for the company are sitting at:
- 0.13 for the present operating margin
- 0.76 for the gross margin
The net margin for Encompass Health Corp stands at 0.07. The total capital return value is set at 0.11. Equity return is now at value 24.53, with 6.18 for asset returns.
Based on Encompass Health Corp (EHC), the company’s capital structure generated 0.59 points at debt to capital in total, while cash flow to debt ratio is standing at 0.35. The debt to equity ratio resting at 1.47. The interest coverage ratio of the stock is 4.22.
Currently, EBITDA for the company is 1.01 billion with net debt to EBITDA at 2.79. When we switch over and look at the enterprise to sales, we see a ratio of 2.23. The receivables turnover for the company is 7.85for trailing twelve months and the total asset turnover is 0.79. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.28.
Conclusion
To wrap up, the performance of Encompass Health Corp (EHC) has been better in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
